HOME >> BIOLOGY >> NEWS
Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators

Margaret Cianci, Executive Director for the Alliance for Cancer Gene Therapy, Inc. (ACGT), a national foundation based in Stamford, Connecticut, announced today the award of national grants to three Young Investigators at major research institutions, totaling $1.5 million over three years, for separate cancer gene therapy research projects relating to neuroblastoma, prostate and ovarian cancers.

The recipients are Dr. Andrew Davidoff at St. Jude Children's Research Hospital, Memphis, Tennessee for the development of anti-angiogenic gene therapy for neuroblastoma, a deadly form of childhood cancer; Dr. Thomas Griffith at the University of Iowa for development and testing of an immunotherapy/vaccine therapy, Ad-5 TRAIL for future clinical trials in patients with prostate cancer; and Dr. Jeffrey Bartlett, at Children's Research Institute in Columbus, Ohio, for tumor targeting/vector development, creating a specific gene therapy delivery vehicle for patients with ovarian cancer.

Gene therapy is a revolutionary new form of treatment. It has emerged in recent years with the remarkable potential not only to deliver a cure for many types of cancers, but also to improve the quality of life with reduced side effects for patients undergoing treatments.

Every year, over a half million people die from cancer and another million are diagnosed with some form of the disease. Conventional therapies, including chemotherapy, surgery, and radiation, while having produced a measure of success with some cancers, have their limitations and can generate adverse side effects for patients.

The research efforts of these Young Investigators, pursuing newly emerging strategies within the cancer gene therapy field, represent significant potential applications for all forms of cancer and an improved quality of life for those being treated for cancer.

1.Anti-Angiogenesis:
Andrew Davidoff, M.D.
St. Jude Children's Research H
'"/>

Contact: Margaret Cianci
info@acgtfoundation.org
203-358-8000
Alliance for Cancer Gene Therapy
3-Mar-2003


Page: 1 2 3 4

Related biology news :

1. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. AACR and The V Foundation form Translational Cancer Research Alliance
4. Ecology lab aids Turtle Survival Alliance
5. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
6. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
7. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
8. Cancer gene MYC emerging as key research target
9. Cancer patient, heal thyself
10. USC researcher named General Motors Cancer Research Scholar
11. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... ... April 30, 2020 , ... ... with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now ... industries. Flagship and Corritori are taking a collaborative approach to empower more confident ...
(Date:4/30/2020)... ... April 29, 2020 , ... ... continued growth – delivering innovative solutions for a wide range of industries including ... government agencies. A month into the new decade, it was clear to company ...
(Date:4/22/2020)... ... ... RCH Solutions (RCH ), a global provider of Bio-IT computing expertise ... Wlodarczyk as Director of Sales and Business Development. Based out of RCH’s location in ... presence across the Northeast. , “We continue to see increased demand for specialized scientific ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... ... translational research, is bringing together thousands of industry leaders, clinicians, research scientists, medical ... two plenary speakers, Carl June, MD, Director of the Center for Cellular Immunotherapies ...
(Date:5/5/2020)... ... 2020 , ... ProductLife Group has marked the next phase in ... after 13 years at Altran, where he was Group VP of Life Sciences and ... a Pharmacist, Xavier was involved in his early career in the development of new ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global ... announced today that Omixon’s founder and chairman Dr. Attila Berces returns as CEO. ... Holotype HLA since 2014 before stepping into the CEO role in 2017. ...
(Date:4/7/2020)... ... April 06, 2020 , ... Red Nucleus, a leading ... has announced the release of at-home virtual learning resources for all client partners. ... and safety of our employees as we continue to implement measures to safeguard ...
Breaking Biology Technology:
Cached News: